Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sarcolemmal KATP channel modulators and cardiac arrhythmias.
Baczkó I, Husti Z, Lang V, Leprán I, Light PE. Baczkó I, et al. Among authors: light pe. Curr Med Chem. 2011;18(24):3640-61. doi: 10.2174/092986711796642472. Curr Med Chem. 2011. PMID: 21774762 Review.
Distinct myoprotective roles of cardiac sarcolemmal and mitochondrial KATP channels during metabolic inhibition and recovery.
Light PE, Kanji HD, Fox JE, French RJ. Light PE, et al. FASEB J. 2001 Dec;15(14):2586-94. doi: 10.1096/fj.01-0188com. FASEB J. 2001. PMID: 11726534
The molecular genetics of sulfonylurea receptors in the pathogenesis and treatment of insulin secretory disorders and type 2 diabetes.
Lang V, Youssef N, Light PE. Lang V, et al. Among authors: light pe. Curr Diab Rep. 2011 Dec;11(6):543-51. doi: 10.1007/s11892-011-0233-8. Curr Diab Rep. 2011. PMID: 21968738 Review.
Resveratrol and derivatives for the treatment of atrial fibrillation.
Baczkó I, Light PE. Baczkó I, et al. Among authors: light pe. Ann N Y Acad Sci. 2015 Aug;1348(1):68-74. doi: 10.1111/nyas.12843. Epub 2015 Jul 23. Ann N Y Acad Sci. 2015. PMID: 26205342 Review.
Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.
Baczko I, Liknes D, Yang W, Hamming KC, Searle G, Jaeger K, Husti Z, Juhasz V, Klausz G, Pap R, Saghy L, Varro A, Dolinsky V, Wang S, Rauniyar V, Hall D, Dyck JR, Light PE. Baczko I, et al. Among authors: light pe. Br J Pharmacol. 2014 Jan;171(1):92-106. doi: 10.1111/bph.12409. Br J Pharmacol. 2014. PMID: 24102184 Free PMC article.
Future perspectives in the pharmacological treatment of atrial fibrillation and ventricular arrhythmias in heart failure.
Baczko I, Leprán I, Kiss L, Muntean DM, Light PE. Baczko I, et al. Among authors: light pe. Curr Pharm Des. 2015;21(8):1011-29. doi: 10.2174/1381612820666141029101305. Curr Pharm Des. 2015. PMID: 25354185 Review.
Syntaxin-1A inhibits cardiac KATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A.
Kang Y, Leung YM, Manning-Fox JE, Xia F, Xie H, Sheu L, Tsushima RG, Light PE, Gaisano HY. Kang Y, et al. Among authors: light pe. J Biol Chem. 2004 Nov 5;279(45):47125-31. doi: 10.1074/jbc.M404954200. Epub 2004 Aug 31. J Biol Chem. 2004. PMID: 15339904
Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel.
Hamming KS, Soliman D, Matemisz LC, Niazi O, Lang Y, Gloyn AL, Light PE. Hamming KS, et al. Among authors: light pe. Diabetes. 2009 Oct;58(10):2419-24. doi: 10.2337/db09-0143. Epub 2009 Jul 8. Diabetes. 2009. PMID: 19587354 Free PMC article.
Plasma membrane KATP channel-mediated cardioprotection involves posthypoxic reductions in calcium overload and contractile dysfunction: mechanistic insights into cardioplegia.
Baczkó I, Jones L, McGuigan CF, Manning Fox JE, Gandhi M, Giles WR, Clanachan AS, Light PE. Baczkó I, et al. Among authors: light pe. FASEB J. 2005 Jun;19(8):980-2. doi: 10.1096/fj.04-3008fje. Epub 2005 Mar 16. FASEB J. 2005. PMID: 15774423
Identification and pharmacological characterization of sarcolemmal ATP-sensitive potassium channels in the murine atrial HL-1 cell line.
Fox JE, Jones L, Light PE. Fox JE, et al. Among authors: light pe. J Cardiovasc Pharmacol. 2005 Jan;45(1):30-5. doi: 10.1097/00005344-200501000-00006. J Cardiovasc Pharmacol. 2005. PMID: 15613976
93 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page